// company-profile

Prime Medicine, Inc.

PRME
ExchangeNasdaqSectorBiological Products, (No Diagnostic Substances)Inc.DEFilings110Insiders34
// api This Prime Medicine, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 7 insiders purchased shares. Buying was led by Kelly Michael Aaron.

// 90-day insight

Over the last 90 days, Prime Medicine, Inc. insiders bought $0 across 8 transactions with no open-market sales.

  • Most active insider: Kelly Michael Aaron with 1 transaction totaling $0.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of Prime Medicine, Inc. as of 2026-03-31

↑ increasing
Total reported AUM
$312.7M
QoQ change
+11.6%
Reporting period
2026-03-31
#1
Alphabet Inc.
CIK 1652044
$57.6M
16.6M shares
#2
STATE STREET CORP
CIK 93751
$22.1M
6.3M shares
#3
ARK Investment Management LLC
CIK 1697748
$21.7M
6.2M shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 5, 2026Kelly Michael AaronPRME
Award
75,000$0.00$0K
Jun 5, 2026Chung WendyPRME
Award
75,000$0.00$0K
Jun 5, 2026Foster-Cheek Kaye IPRME
Award
75,000$0.00$0K
Jun 5, 2026Cahill ThomasPRME
Award
75,000$0.00$0K
Jun 5, 2026NELSEN ROBERTPRME
Award
75,000$0.00$0K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.